Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

A prestigious scientific journal Wednesday took the unusual step of retracting some high-profile research that had generated international excitement about stem cell research.

The British scientific journal Nature retracted two papers published in January by scientists at the Riken research institute in Japan and at Harvard Medical School that claimed that they could create stem cells simply by dipping skin and blood cells into acid.

Government warnings that antidepressants may be risky for adolescents, and the ensuing media coverage, appear to have caused an increase in suicide attempts among young people, researchers reported Wednesday.

A study involving the health records of more than 7 million people between 2000 and 2010 found a sharp drop in antidepressant use among adolescents and young people and a significant increase in suicide attempts after the Food and Drug Administration issued its warnings.

An alarm sounds on Ed Damiano's night stand in the middle of the night. He jumps out of bed and rushes into his son's room next door.

His son, David, has Type 1 diabetes. The 15-year-old sleeps hooked up to a monitor that sounds an alarm when his blood sugar gets too low. If it drops sharply, David could die in his sleep.

"The fear is that there's going to be this little cold limb, and I screwed up. It's all on me," Damiano says.

But when he touches David's hand, he's warm. He's OK. Damiano says, "That's the moment of relief."

Cigarette smoking among U.S. high school students has dropped to the lowest level in 22 years, federal health officials reported Thursday.

The percentage of students who reported smoking a cigarette at least one day in the last 30 days fell to 15.7 percent in 2013, according to the National Youth Risk Behavior Survey, a large federal survey that has been tracking youth smoking since 1991.

Robin Reath was getting a routine checkup recently when her doctor brought up something new about cervical cancer screening.

"We might be doing something a little bit different than what we've been doing in the past when we've screened you," said Dr. Andrea Singer, an internist at the MedStar Georgetown University Hospital in Washington.

The second U.S. case of a dangerous new virus from the Middle East has been found in Florida, the Centers for Disease Control and Prevention said Monday.

The patient is a health care worker from Jeddah, Saudi Arabia, who developed symptoms May 1 while traveling to Orlando, Fla., to visit family, the CDC said.

The World Health Organization is revisiting a question that's been the subject of intense debate for decades: whether to destroy the only known samples of the smallpox virus.

Transcript

AUDIE CORNISH, HOST:

From NPR News, this is ALL THINGS CONSIDERED. I'm Audie Cornish.

ROBERT SIEGEL, HOST:

And I'm Robert Siegel. The first case of MERS has been confirmed in the U.S. MERS stands for Middle East Respiratory Virus Syndrome. Health officials say a man in Indiana was hospitalized on Monday and is in stable condition. NPR's Rob Stein reports that while precautions are being taken to contain the virus, there is no reason for widespread alarm.

Scientists reported Thursday they had figured out a way to make primitive human sperm out of skin cells, an advance that could someday help infertile men have children.

"I probably get 200 emails a year from people who are infertile, and very often the heading on the emails is: Can you help me?" says Renee Reijo Pera of Montana State University, who led the research when she was at Stanford University.

Ron Strang was on patrol in Afghanistan when a primitive land mine exploded.

"When it went off, it came across the front of my body," Strang says. Though he survived the blast, his left leg was never the same. Shrapnel destroyed most of the muscle on his left thigh. He used to run, swim and hike. But even after he recovered, those days of carefree movement were gone.

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

MELISSA BLOCK, HOST:

From NPR News, this is ALL THINGS CONSIDERED. I'm Melissa Block.

AUDIE CORNISH, HOST:

And I'm Audie Cornish.

The Food and Drug Administration Thursday proposed regulating e-cigarettes for the first time.

The agency unveiled a long-awaited rule that would give it power to oversee the increasingly popular devices, much in the way that it regulates traditional cigarettes.

A key government panel Tuesday voted unanimously against approval of a powerful opioid prescription painkiller intended to provide faster relief with fewer side effects.

At the conclusion of a hearing, the Food and Drug Administration advisory committee voted 14-0 against recommending that the agency approve Moxduo, the first drug to combine morphine and oxycodone into one capsule.

The Food and Drug Administration is trying to decide whether to approve a powerful new prescription painkiller that's designed to relieve severe pain quickly, and with fewer side effects than other opioids.

While some pain experts say the medicine could provide a valuable alternative for some patients in intense pain, the drug (called Moxduo) is also prompting concern that it could exacerbate the epidemic of abuse of prescription painkillers and overdoses.

A lot of us know what can happen when we get hungry. We get grumpy, irritable and sometimes nasty.

There's even a name for this phenomenon: "Hangry, which is a combination of the words hungry and angry," says psychologist Brad Bushman from Ohio State University.

Pages